Quarterly report [Sections 13 or 15(d)]

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.25.3
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balance at Dec. 31, 2023 $ 17 $ 1,378,881 $ 8 $ (1,407,550) $ (28,644)
Balance (in shares) at Dec. 31, 2023 17,482,513        
Increase (Decrease) in Stockholders' Equity          
Net income       (8,247) (8,247)
Net change in unrealized gain (loss) on short-term investments     (13)   (13)
Issuance of common stock upon exercise of options   89     89
Issuance of common stock upon exercise of options (in shares) 9,066        
Issuance of common stock upon vesting of RSUs (in shares) 48,658        
Stock-based compensation expense   5,144     5,144
Balance at Mar. 31, 2024 $ 17 1,384,114 (5) (1,415,797) (31,671)
Balance (in shares) at Mar. 31, 2024 17,540,237        
Balance at Dec. 31, 2023 $ 17 1,378,881 8 (1,407,550) (28,644)
Balance (in shares) at Dec. 31, 2023 17,482,513        
Increase (Decrease) in Stockholders' Equity          
Net income         3,144
Net change in unrealized gain (loss) on short-term investments         3
Balance at Sep. 30, 2024 $ 17 1,389,742 11 (1,404,406) (14,636)
Balance (in shares) at Sep. 30, 2024 17,612,980        
Balance at Mar. 31, 2024 $ 17 1,384,114 (5) (1,415,797) (31,671)
Balance (in shares) at Mar. 31, 2024 17,540,237        
Increase (Decrease) in Stockholders' Equity          
Net income       (1,030) (1,030)
Net change in unrealized gain (loss) on short-term investments     (4)   (4)
Issuance of common stock upon exercise of options   252     252
Issuance of common stock upon exercise of options (in shares) 36,130        
Issuance of common stock upon vesting of RSUs (in shares) 17,750        
Stock-based compensation expense   2,539     2,539
Balance at Jun. 30, 2024 $ 17 1,386,905 (9) (1,416,827) (29,914)
Balance (in shares) at Jun. 30, 2024 17,594,117        
Increase (Decrease) in Stockholders' Equity          
Net income       12,421 12,421
Net change in unrealized gain (loss) on short-term investments     20   20
Issuance of common stock upon exercise of options   158     158
Issuance of common stock upon exercise of options (in shares) 16,363        
Issuance of common stock upon vesting of RSUs (in shares) 2,500        
Stock-based compensation expense   2,679     2,679
Balance at Sep. 30, 2024 $ 17 1,389,742 11 (1,404,406) (14,636)
Balance (in shares) at Sep. 30, 2024 17,612,980        
Balance at Dec. 31, 2024 $ 18 1,393,325 10 (1,390,065) 3,288
Balance (in shares) at Dec. 31, 2024 17,710,216        
Increase (Decrease) in Stockholders' Equity          
Net income       11,446 11,446
Net change in unrealized gain (loss) on short-term investments     (12)   (12)
Issuance of common stock upon exercise of options   484     484
Issuance of common stock upon exercise of options (in shares) 30,892        
Issuance of common stock upon vesting of RSUs (in shares) 125,783        
Stock-based compensation expense   3,361     3,361
Balance at Mar. 31, 2025 $ 18 1,397,170 (2) (1,378,619) 18,567
Balance (in shares) at Mar. 31, 2025 17,866,891        
Balance at Dec. 31, 2024 $ 18 1,393,325 10 (1,390,065) 3,288
Balance (in shares) at Dec. 31, 2024 17,710,216        
Increase (Decrease) in Stockholders' Equity          
Net income         98,959
Net change in unrealized gain (loss) on short-term investments         86
Balance at Sep. 30, 2025 $ 18 1,408,601 96 (1,291,106) 117,609
Balance (in shares) at Sep. 30, 2025 18,143,984        
Balance at Mar. 31, 2025 $ 18 1,397,170 (2) (1,378,619) 18,567
Balance (in shares) at Mar. 31, 2025 17,866,891        
Increase (Decrease) in Stockholders' Equity          
Net income       59,613 59,613
Net change in unrealized gain (loss) on short-term investments     8   8
Issuance of common stock upon exercise of options   418     418
Issuance of common stock upon exercise of options (in shares) 52,295        
Issuance of common stock upon vesting of RSUs (in shares) 17,908        
Stock-based compensation expense   3,328     3,328
Balance at Jun. 30, 2025 $ 18 1,400,916 6 (1,319,006) 81,934
Balance (in shares) at Jun. 30, 2025 17,937,094        
Increase (Decrease) in Stockholders' Equity          
Net income       27,900 27,900
Net change in unrealized gain (loss) on short-term investments     90   90
Issuance of common stock upon exercise of options   4,271     4,271
Issuance of common stock upon exercise of options (in shares) 206,890        
Stock-based compensation expense   3,414     3,414
Balance at Sep. 30, 2025 $ 18 $ 1,408,601 $ 96 $ (1,291,106) $ 117,609
Balance (in shares) at Sep. 30, 2025 18,143,984